Tuba Ovarian Abse: 61 Olgunun Değerlendirilmesi

Yıl 2012, Cilt: 19 Sayı: 2, 47 - 50, 30.06.2012

Önder Kaplan Mehmet Güney Murat Yüksel

Öz

Amaç: Tuba ovarayan abse'de klinik ve laboratuar sonuçlarını değerlendirmek, tedavi yöntemlerini incelemektir.
Materyal ve metod: Mart 1998 – Aralık 2011 tarihleri arasında Süleyman Demirel Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum kliniğinde yatırılıp tedavisi yapılan 61 olgu retrospektif olarak incelendi. Olguların klinik özellikleri, risk faktörleri ve tedavi yöntemleri araştırıldı.
Bulgular: Tuba ovarian abse öncesinde tedavi edilmemiş pelvik İnflamatuar hastalık öyküsü %54 (n=33) hastada rastlandı. Rahim içi araç kullanım süresine bakıldığında ortalama 10±4,1 yıl olarak görüldü. Hastaların %60'nın (n=37) multipar olduğu izlendi. Tanı anında ve perioperatif dönemde yapılan ultrason ve bilgisayarlı tomografi sonuçlarına göre Tuba ovarian abse kitlelerinin çapları ortalama 7,1±2,7 cm olarak görüldü (r=2-15cm). Olguların tanı alıp operasyona alınma süresi incelendiğinde 2,4±1,3 gün olarak bulundu.
Sonuçlar: Mortalite ve morbidite yönünden önemli bir hastalık olan Tuba ovarian absede hastanın yaşı, gebelik istemi ve klinik tablo göz önünde bulundurularak hastaya en uygun tedavi yöntemi seçilmelidir.
Anahtar Kelimeler: Tubaovaryan Abse, Pelvik İnflamatuar Hastalık, Medikal Tedavi, Cerrahi Tedavi

Abstract

Objective: to evaluate clinical and laboratory results of tuboovarian abscess and to invastigate treatment modalities.
Material and Methods: 61 cases admitted to department of obstetric and gynecology, medical faculty of Süleyman Demirel between 1998 and 2011were analysed retrospectively. The clinical presentation, risk factors and treatment methods were examined
Results: A history of pelvic inflammatory disease were observed in 54% (n=33) untreated patients before the tuboovarian abscess. Intra uterin device usage was seen as an average of 10±4,1 years. 60% (n=37) of patients were multipar. Ultrasound and computed tomography in the perioperative period and the masses of the patients according to the results mean: 7.1 ± 2.7 cm in diameter were observed (r=2-15cm). Mean time of duration between diagnosed and surgery was 2.4 ± 1.3 days.
Conclusion: Choice of treatment in tuboovarian abscess which is associated with significant morbidity should be made regarding age, clinical features and fertility desire of patients.
Key Words: Tuboovarian abscess, Pelvic Inflammatory Disease, Medical Treatment, Surgical Treatment.

Anahtar Kelimeler

Tubaovaryan Abse, Pelvik Ýnflamatuar Hastalýk, Medikal Tedavi, Cerrahi Tedavi

Kaynakça

• Walker CK, Landers DV. Pelvic abscesses: new trends inmanagement. Obstet Gynecol Surv 1991;46:615–624.
• Washington AE, Aral SO, Wolner-Hanssen P, et al. Assessingrisk for pelvic inflammatory disease and its sequelae. JAMA1991;266:2581–2586.
• Velebil P, Wingo PA, Xia Z, Wilcox LS, Peterson HB,. Rate of hospitalizasyon for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol. 1995;86(5):764-9.
• Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarianabscesses. Clin Obstet Gynecol 1993;36:433–444.
• Paavonen J, Teisala K, Heinonen PK, et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1987;94:454–460.
• Beckmann CR, Sampson MB. Ultrasonographic diagnosis of interstitial ectopic pregnancy. J Clin Ultrasound 1984;12:304–306.
• Granberg S, Gjelland K, Ekerhovd E. Best practice and research.ÊClinical Obstetrics and Gynecology. 2009;23(5):667–678.
• Krivak TC, Cooksey C, Propst AM. Tubo-ovarian abscess: diagnosis, medical and surgical management.
• Compr Ther. 2004;30(2):93-100.
• Porpora MG, Gomel V. The role of laparoscopy in the management of pelvic pain in women of reproductive age. Fertil Steril. 1997;68(5):765-79.
• Güney M, Erdemoðlu E, Mungan T. Tubaovarian abscess: Analysis of 25 cases and review of literature. Journal of Obstetrics and Gynecology. 2007;5(4):1210- 1212.
• Hsiao SM, Hsieh FJ, Lien YR. Tuboovarian abscesses in postmenapausal women. Taiwan J Obstet. Gynecol.2006;45(3):234-8.
• Lipscomb GH, Ling FW. Tubo-ovarian abscess in postmenapousal patients. South Med J.1992;85(7):696- 9.
• Paik Ck, Waetjen LE, Xing G, Dai J, Sweet Rl. Hospitalizations for pelvic inflamatory disease and tuboovarian abscess. Obstet Gynecol.2006;107(3):611- 6.
• Fabiszewski NL, Sumkin JH, Johns JM, Contemporary radiologic percutaneous abscess dranage in pelvis. Clin Obstet Gynecol.1993;36:445-56.
• Martens MG: Pelvic inflemmatory disease. In Rock JA; Jones HW: Te Linde’s Operative Gynecology, Lippincott Williams&Wilkins,9th edition,675-704,2003.
• Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol 1985;151:1098–1110.
• McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ranson SB. Medically round, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol.1998:178(6):1272-8.
• Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess:a retrospective review. Am J Obstet Gynecol. 1980;1;138(7pt2):1055-8.
• Shulman A, Maymon R, Shapiro A, Bahary C. Percutaneuscatheter dranaige of tuba-ovarian abscesses. Obstet Gynecol. 1992;80(3pt2):555-7
• Caspi B, zalel Y, Or Y, Bar Dayan Y, Appelman Z, Katz Z. Sonographically guided aspiration:al alternative therapy dor tuboovarian abscess. Ultrasound Obstet Gynecol.1996;7(6):439-42
• Henry-Suchet J, Soler A, Loffredo V. Laparoscopic treatment of tuboovarian abscesses. J Reprod Med 1984;29:579–582.
• Raiga J, Denoix S, Canis M, et al. [Laparoscopic treatment of adnexal abscesses. A series of 39 patients]. J Gynecol Obstet Biol Reprod (Paris) 1995;24:381–385.
• Buchweitz O, Malik E, Kressin P, et al. Laparoscopic management of tubo-ovarian abscesses: retrospective analysis of 60 cases. Surg Endosc 2000;14:948–950.